Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1711-1718

  Hui, Jingyi ^a,b   Mancini, Maryline ^b   Li, Guangdi ^a   Wang, Yuan ^a   Tiollais, Pierre ^b   Michel, Marie Louise ^b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b INSERM   (France)

Author keywords

Genetic vaccine; Hepatitis; Transgenic mice

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER CELL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS GENOME; VIRUS PARTICLE;

ANIMALS; BINDING SITES; COS CELLS; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNIZATION; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PLASMIDS; PROTEIN PRECURSORS; RECEPTORS, VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0344141393     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00430-7     Document Type: Conference Paper

References (28)

1. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 317:1985;489-495.
2. World Health Organization Expert Committee on Biological Standardization Bull. WHO. 66:1988;443-455.
3. Ganem D., Varmus H.E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:1987;651-693.
4. Neurath A.R., Kent S.B.H., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 46:1986;429-436.
5. Neurath A.R., Seto B., Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus neutralizing and protective. Vaccine. 7:1989;234-236.
6. Xu X., Li G.D., Kong Y.Y., Yang H.L., Zhang Z.C., Cao H.T., Wang Y. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C-terminus: expression, antigenicity and immunogenicity. J. Gen. Virol. 75:1994;3673-3677.
7. Whalen R.G., Davis H.L. DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen. Clin. Immunol. Immunopathol. 75:1995;1-12.
8. Davis H.L., Michel M.-L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1993;1847-1851.
9. Davis H.L., Schirmbeck R., Reimann J., Whalen R.G. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T-lymphocyte response to the hepatitis B envelope protein. Human Gene Ther. 6:1995;1447-1456.
10. Geissler M., Tokushige K., Chante C.C., Zurawski V.R., Wands J.R. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology. 112:1997;1307-1320.
11. Davis H.L., McCluskie M.J., Gerin J.L., Purcell R.H. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA. 93:1996;7213-7218.
12. Mancini M., Hadchouel M., Davis H.L., Whalen R.G., Tiollais P., Michel M.-L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. USA. 93:1996;12496-12501.
13. Michel M.-L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA. 92:1995;5307-5311.
14. Davis H.L., Whalen R.G., Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:1993;151-159.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, 1989.
16. Heermann K.H., Goldmann U., Schwarts W., Seyffarth T., Baumgerten H., Gerlich W.H. Large surface proteins of hepatitis B virus containing preS sequence. J. Virol. 52:1984;396-402.
17. Babinet C., Farza H., Morello D., Hadchouel M., Pourcel C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science. 230:1985;1160-1163.
18. Farza H., Salmon A.-M., Hadchouel M., Moreau J.-L., Babinet C., Tiollais P., Pourcel C. Hepatitis B surface antigen gene expression is regulated by sex-steroids and glucocorticoids in transgenic mice. Proc. Natl. Acad. Sci. USA. 84:1987;1187-1191.
19. Mancini M., Davis H.L., Tiollais P., Michel M.-L. DNA-based immunization against the envelope proteins of the hepatitis B virus. J. Biotechnol. 44:1996;47-57.
20. Schirmbeck R., Melber K., Kuhröber A., Janowicz Z.A., Reimann J. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T-lymphocyte responses in vivo. J. Immunol. 152:1994;1110-1119.
21. Buseyne F., Février M., Garcia S., Gougeon M.L., Rivière Y. Dual functions of a human immunodeficiency virus (HIV) specific cytotoxic T-lymphocytes (CTL) clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. Virology. 225:1996;248-253.
22. Schirmbeck R., Böhm W., Ando K., Chisari F.V., Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T-lymphocytes in nonresponder mice. J. Virol. 69:1995;5929-5934.
23. Le Borgne S., Mancini M., Le Grand R., Schleef M., Dormont D., Tiollais P., Riviere Y., Michel M.-L. In vivo induction of specific cytotoxic T-lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology. 240:1998;304-315.
24. Major M.E., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trepo C., Inchauspé G. DNA-based immunization with chimeric vectors for the induction of immune response against the hepatitis C virus nucleocapsid. J. Virol. 69:1995;5798-5805.
25. Hui J, Li GD, Kong YY, Wang Y. DNA-based immunization against modified hepatitis B surface antigen carrying preS1 and preS2 epitopes. Chin. Sci. Bull., in press.
26. Milich D.R. T- and B-cell recognition of hepatitis B viral antigens. Immunol. Today. 9:1988;380-386.
27. Thellmann L., Klinkert M.-Q., Gmelin K., Kommerell B., Pfaff E. Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus (HBV) infection. J. Hepatol. 4:1987;22-28.
28. Thoma HA, Hemmerling AE, Koller E, Kapfer G. Does preS2 have the same effect in improving the HBV immune response as preS1? In: Hollinger FB, Lemon SM, Margolis HS, editors. Viral hepatitis and liver disease. William & Wilkins, Baltimore, 1991. p. 736-41.